Key facts
- This page summarizes Harvey B. Grossblatt's Form 4 filing for UNIVERSAL SAFETY PRODUCTS, INC. (UUU).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 Oct 2025, 16:30.
Harvey B. Grossblatt - 20 Oct 2025 Form 4 Insider Report for UNIVERSAL SAFETY PRODUCTS, INC. (UUU)
- Reporting relationship
- Chairman, President and CEO, Director
- Issuer ticker
- UUU
- Reported as of
- 20 Oct 2025
- Net transaction value
- $0
- Reporting owner signature
- By: /s/ Harvey B. Grossblatt
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Harvey B. Grossblatt filed Form 4 for UNIVERSAL SAFETY PRODUCTS, INC. (UUU) on 23 Oct 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001232192
Primary reporting owner
GROSSBLATT HARVEY B
- Relationship
- Chairman, President and CEO, Director
- Address
- 11407 CRONHILL DRIVE, SUITE A, OWINGS MILLS
- Signature
- By: /s/ Harvey B. Grossblatt
- Signature date
- 23 Oct 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
UUU
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 20 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $3.40
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The stock options (the "Options") were granted on August 27, 2025, subject to stockholder approval. The Options vested on October 20, 2025, the date of stockholder approval.
Footnote F2
The Options are exercisable as soon as the NYSE American approves the supplemental listing application relating to the issuance of the common stock underlying the Options.